Detailed Narrative
Operational Momentum and Portfolio Performance
PACS Group reported strong Q2 FY26 results, with revenue up 9.1% and adjusted EBITDA up 25%, reflecting sustainable operating model execution. The existing portfolio drove performance, with same-store revenue growth of 5.8% and a 150 basis point increase in same-store occupancy, demonstrating organic growth and the effectiveness of their locally led, centrally supported model. Overall occupancy for the total skilled nursing portfolio increased by 180 basis points to 90.4%, significantly above the industry average of 79.5%.
Quality Outcomes and Clinical Excellence
The company highlighted significant improvements in quality, with 83.6% (239 facilities) of skilled nursing facilities achieving 4 or 5-star CMS ratings. A case study of a California facility successfully graduating from a 'special focused facility' designation underscored PACS's ability to turn around clinically and operationally challenged assets through strong local leadership and support. This focus on quality is seen as a primary driver of financial success, building trust with hospitals, payers, and patients.
Acquisition Strategy and Eduro Transaction
PACS is returning to an active acquisition phase, having closed on 20 of 34 skilled nursing facilities from Eduro Healthcare in Texas on August 1, with the remaining 14 expected to close in Q3/Q4. This transaction adds significant density in Texas and expands presence in other markets, aligning with PACS's disciplined strategy to improve clinical quality and create long-term value. The acquired Eduro facilities, while having positive EBITDA margins, are expected to see further improvement in quality measures, occupancy, and skilled mix under PACS's model.
Financial Strength and Capital Allocation
The company ended Q2 with $756.6 million in available liquidity, including $164.5 million of cash, and a net leverage of 0.1x, providing flexibility for investments, acquisitions, and real estate ownership. They deployed $104.3 million to acquire real estate in Q2, bringing the H1 total to $190.8 million, now owning the underlying real estate for 64 of their operated facilities. This conservative leverage profile is considered an important strategic advantage.
Guidance Increase and Future Outlook
PACS raised its full-year revenue guidance to $5.75 billion-$5.85 billion and adjusted EBITDA guidance to $640 million-$660 million, reflecting confidence in existing portfolio performance and integration capabilities. The updated guidance includes a modest contribution from the 20 closed Eduro facilities but excludes the remaining 14 and any future acquisitions. The company anticipates continued high performance in the second half of the year.
Internal Controls and Government Investigations
The company is actively remediating material weaknesses in internal control over financial reporting, expecting completion by year-end, and continues to cooperate with ongoing government investigations, expressing confidence in their ability to navigate these matters responsibly. They emphasize that financial statements are prepared in accordance with GAAP and fairly present the company's financial position.
Technology and AI Integration
PACS is actively exploring and implementing AI tools to enhance operational efficiencies, particularly in patient assessment and documentation. The goal is to identify patient needs, capture care elements, save clinician time, and improve quality measures. This strategic use of technology aims to free up clinicians for direct patient care and potentially expand margins, while ensuring compliance with privacy regulations.